Written by: David A. Kvancz, MS, RPh, FASHP, Cynthia Blankenship, Esq and Kevin Roche, PhD

This article in Pharmacy Practice News, co-written by Visante’s David Kvancz, MS, RPh, FASHP, reviews important considerations and provides a check list to guide the decision-making process for a health system-based 503B sterile compounding program.

Read full article here

Share this on Twitter: